Therefore, the entering of this transaction being considered as Type 2 transaction under the Notification on Acquisition or Disposal of Assets. Therefore, the Company is required to immediately disclose the

, paid-up capital, expiration term (if applicable), REIT Manager, and Trustee; - fact sheet regarding main asset as of financial year-end date, type of investment, investment price, method of procuring

Company Limited Factsheet Information as of XX XX XXXX ABCD Mutual Fund Unit Class SRI Fund Class code Type of mutual fund / Peer group of mutual funds Risk Level Low 1 2 3 4 5 6 7 8 High Risk Profile

consolidated financial statements of the Company for the year ended 31 December 2017, which is equal to 15 percent or higher, but less than 50 percent, this is considered as a Type 2 transaction pursuant to the

based on the audited consolidated financial statements of the Company for the year ended 31 December 2017, which is equal to 15 percent or higher, but less than 50 percent, this is considered as a Type 2

business and electricity production business. Therefore, there was no similar type of business in the industry that can be used as a benchmark for comparison. Not include transaction related to the novation

····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ···...

Company and its subsidiaries was THB 2,864.65 million which increased by THB 126.41 million or by 4.62% compared to 2018. The significant changes of each type of the revenues can be explained as follows: 1

www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 2019 2018 Change MB

of each type of the revenue can be explained as follows: 1. REVENUE FROM SALES OF MANUFACTURING AND TRADING GOODS In 2019, the revenue of Company and its subsidiaries was THB 2,776.38 million, equaled